Explore more publications!
Health & Wellness Today New York
Submit Press Release

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 17, 2025

Leading Neurovascular Specialist Dr. Jeremy M. Liff Brings Advanced Stroke and Brain Aneurysm Treatment to the Tri-State
September 17, 2025

Leading Neurovascular Specialist Dr. Jeremy M. Liff Brings Advanced Stroke and Brain Aneurysm Treatment to the Tri-State

Indeterminate EIN Presswire
Hair We Share to Participate in the Wave Wellness & Beauty Expo and Share Its Mission of Restoring Confidence
September 17, 2025

Hair We Share to Participate in the Wave Wellness & Beauty Expo and Share Its Mission of Restoring Confidence

Indeterminate EIN Presswire
Eltegra Inc. Launches EltegraAI, Revolutionizing AI-Powered Product Management for Enterprise Accounts
September 17, 2025

Eltegra Inc. Launches EltegraAI, Revolutionizing AI-Powered Product Management for Enterprise Accounts

Indeterminate EIN Presswire
GlobalEdgeMarkets Partners with Business Finland to Launch the ‘Find Your Superposition in Finland’ Campaign
September 17, 2025

GlobalEdgeMarkets Partners with Business Finland to Launch the ‘Find Your Superposition in Finland’ Campaign

Indeterminate EIN Presswire
Experts urge Congress to reject bill that incorrectly conflates FGM and gender-affirming care
September 17, 2025

Experts urge Congress to reject bill that incorrectly conflates FGM and gender-affirming care

Indeterminate EIN Presswire
Creative Diagnostics Introduces OGN™ Tumor-derived Organoid Culture Kits to Advance Cancer Research
September 17, 2025

Creative Diagnostics Introduces OGN™ Tumor-derived Organoid Culture Kits to Advance Cancer Research

Indeterminate EIN Presswire
The Brookbush Institute Publishes a NEW Article: 'Drop Sets: Comprehensive Systematic Review & Training Recommendations'
September 17, 2025

The Brookbush Institute Publishes a NEW Article: 'Drop Sets: Comprehensive Systematic Review & Training Recommendations'

Indeterminate EIN Presswire
Diana Morales selected as Top CEO and Biotech Consultant by IAOTP
September 17, 2025

Diana Morales selected as Top CEO and Biotech Consultant by IAOTP

Indeterminate EIN Presswire
New Back to School E-book Offers Success Strategies For Autism and Special Needs Parents
September 17, 2025

New Back to School E-book Offers Success Strategies For Autism and Special Needs Parents

Indeterminate EIN Presswire
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
September 17, 2025

Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study

Indeterminate GlobeNewswire
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
September 17, 2025

Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering

Indeterminate GlobeNewswire
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
September 17, 2025

Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years

Indeterminate GlobeNewswire
Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation
September 17, 2025

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation

Indeterminate GlobeNewswire
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
September 17, 2025

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe

Indeterminate GlobeNewswire
NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1
September 17, 2025

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

Indeterminate GlobeNewswire
NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1
September 17, 2025

NANOBIOTIX annonce de nouveaux résultats de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle en traitement de deuxième ligne ou plus chez des patients atteints de mélanome cutané résistant aux anti-PD-1

Indeterminate GlobeNewswire
Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM
September 17, 2025

Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM

Indeterminate GlobeNewswire
CooperCompanies Announces Expanded Share Repurchase Program
September 17, 2025

CooperCompanies Announces Expanded Share Repurchase Program

Indeterminate GlobeNewswire
Regional Health Properties, Inc. Completes Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares
September 17, 2025

Regional Health Properties, Inc. Completes Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares

Indeterminate GlobeNewswire
Vaxart Appoints W. Mark Watson as Lead Independent Director
September 17, 2025

Vaxart Appoints W. Mark Watson as Lead Independent Director

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions